- Crown Trading
- Posts
- Crown's Top 3 Stock Picks For The Week
Crown's Top 3 Stock Picks For The Week
Here are our top 3 stock picks for the week...
Crown Trading
April 04, 2025
In partnership with
GOOD MORNING
Here’s everything you need to know today: There are currently 14,157 publicly traded companies in the United States and over 1000+ articles released about S&P500 companies alone every single day. Today we will be showing you our top 3 stock picks we have hand picked for this week:
1 year performance
WAY - 77%
LMND - 99%
TEM - 22%
This Week (Here’s our top 3 stock picks)
Waystar Holding Corp. (WAY)
1 Year Performance: +77%
Category: Growth
Market Cap: $6.4B
Company Info:
Waystar Holding Corp. is a healthcare technology company that develops cloud-based software solutions aimed at simplifying healthcare payments for providers. Their platform offers a comprehensive suite of tools, including financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions, enabling healthcare organizations to optimize financial performance and focus more on patient care.
Why it’s a buy:
Waystar Holding Corp. (NASDAQ: WAY) presents a compelling investment opportunity due to its strong financial performance and strategic market positioning in the healthcare technology sector.
In fiscal year 2024, Waystar reported revenue of $944 million, marking a 19% year-over-year increase, and adjusted EBITDA of $383 million, up 15% from the previous year.
The company’s net revenue retention rate stands at 110%, indicating robust client retention and expansion.
Additionally, the stock is currently trading at $37.33, suggesting potential for appreciation.
These factors collectively position Waystar for sustained growth and make its stock an attractive consideration for investors seeking exposure to the healthcare technology industry.
Revenue:
Lemonade Inc. (LMND)
1 Year Performance: +99%
Category: Growth
Market Cap: $2.3B
Company Info:
Lemonade, Inc. is an American insurance company that offers renters', homeowners', car, pet, and term life insurance in the United States, as well as contents and liability policies in Germany and the Netherlands, and renters' insurance in France. Founded in 2015 and headquartered in New York City, Lemonade utilizes artificial intelligence and chatbots to provide a seamless, digital-first experience for customers, aiming to simplify and expedite the insurance process.
Why it’s a buy:
Lemonade, Inc. (NYSE: LMND) has demonstrated strong financial performance and strategic growth initiatives, making it a compelling investment opportunity.
In the fourth quarter of 2024, Lemonade reported revenue of $148.8 million, a 29% year-over-year increase, and a net loss of $30 million, which is an improvement from the $42.4 million loss in the same quarter of the previous year. The company's gross profit also saw a significant rise, reaching $63.9 million, up 90% year-over-year, leading to a gross profit margin expansion to 43%.
Additionally, Lemonade achieved its first cash flow positive year, with $48 million in positive cash flow, and reported a gross loss ratio of 63%, the lowest in its history, indicating improved underwriting performance.
These factors, combined with Lemonade's innovative use of artificial intelligence to enhance customer experience and streamline operations, position the company favorably for sustained growth in the insurance technology sector.
Revenue:
Tempus AI Inc. (TEM)
1 Year Performance: +22%
Category: Momentum
Market Cap: $8.5B
Company Info:
Tempus AI, Inc. is a health technology company that leverages artificial intelligence (AI) to provide precision medicine solutions across various medical fields, including oncology, cardiology, radiology, and mental health. Founded in 2015 by Eric Lefkofsky in Chicago, Illinois, Tempus has developed one of the world's largest libraries of clinical and molecular data, enabling healthcare providers to deliver personalized patient care through advanced data analytics and AI-driven insights.
Why it’s a buy:
Tempus AI, Inc. (NASDAQ: TEM) has demonstrated strong financial performance and strategic growth initiatives, positioning it as a compelling investment opportunity in the healthcare technology sector.
In 2024, the company reported annual revenue of approximately $693.4 million, marking a 30.4% year-over-year increase, with gross profit growing by 33.2% to $381.1 million.
The fourth quarter saw an accelerated revenue growth of 35.8%, reaching $200.7 million, driven by a 44.6% increase in the Data and Services segment.
Additionally, Tempus AI's acquisition of Ambry Genetics and the launch of new products have expanded its capabilities in genomic profiling and AI diagnostics, enhancing its market position.
These factors collectively suggest that Tempus AI is well-positioned for sustained growth in the evolving AI-driven healthcare landscape.
Revenue:
Get more picks like Tempus…
If you are interested in receiving more of our top stock picks like Tempus sign up to our Elite Membership where you get access to:
3 curated emails a week (monday, wednesday, friday) with 2 hand-picked Elite stocks in each email
1 report a week (sunday) on the general market and state of where the stock market is it currently
Direct email contact with myself to ask any questions regarding stock knowledge
Exclusive offers from any of our partners (trade software, brokers, news sources, etc.)
2 week money back guarantee (100% refund)
Join today for only $19.99/month or $199.99/year.
Otherwise, stay tuned for our next free release at 8:15 am EST (Monday and Friday).
OUR RECENT ELITE TRADES (updated Mar 12/25)
Date Posted | Ticker | Price | Current Price | Gain/Loss |
|---|---|---|---|---|
Jan 10/25 | SE | $105 | $129 | 22.8% |
Jan 13/25 | DOCS | $49 | $64 | 30.6% |
Jan 15/25 | SPOT | $476 | $535 | 12.4% |
Jan 10/25 | BB | $3.9 | $4.37 | 12.1% |
Jan 13/25 | DAVE | $86 | $81 | 6.1% |
If you invested $10,000 in each of these stocks you’d be sitting on:
$58,340
In less than 2 months...
Join Crown Elite today for only $19.99/month or $199.99/year
and get our Elite Picks Emailed to you every Monday, Wednesday and Friday.
Elon Dreams, Mode Mobile Delivers
As Elon Musk said, “Apple used to really bring out products that would blow people’s minds.”
Thankfully, a new smartphone company is stepping up to deliver the mind-blowing moments we've been missing.
Turning smartphones from an expense into an income stream, Mode has helped users earn an eye-popping $325M+ and seen an astonishing 32,481% revenue growth rate over three years.
They’ve just been granted the stock ticker $MODE by the Nasdaq, and you can still make an investment in their pre-IPO offering.
Thank you for your time!
I’m sure you get hundreds of emails a day so I thank you for taking the time to read ours. Please follow us on our social media channels below where we post other new and different content related to investing, personal finance, and trading.
Stay tuned for our next free release at 8:15 am EST (Monday and Friday).